$12.43
+1.26 (+11.28%)
USD · as of 2026-08-18 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where TRIB is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
2 observational
Held by 1 tracked-famous manager (SUSQUEHANNA INTERNATIONAL GROUP, LLP) · FINRA short interest 1.0 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|
| Clinical Study to Validate the Use of a New Point of Care Troponin I TestNCT02620397observationalClinical performance of the Meritas Troponin I test | — | Unknown status | Acute Coronary Syndrome | 1,500 | Oct 2015actual | 2015-12-15 |
| 99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I TestNCT02638311observational99th percentile for Troponin results determined from whole blood and plasma in apparetly healthy volunteer population | — | Completed | Acute Coronary Syndrome | 769 | Jul 2015actual | 2015-12-23 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19